Quarterly / Interim Statement/Quarter ResultsSCHOTT Pharma records good start into fiscal year and confirms full year outlook 13.02.2025 / 07:00 CET/CESTThe issuer is solely responsible for the ...

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word (s): Quarterly / Interim Statement/Quarter Results SCHOTT Pharma records good start into fiscal year and confirms full year outlook 13.02.2025 / ...

Owen Ryan; Chairman of the Board, Co-Chief Executive Officer; Blackline Inc Therese Tucker; Co-Chief Executive Officer, Executive Director; Blackline Inc Good day, and thank you for standing by.

Q4 2024 Results Earnings Conference Call February 12, 2025 4:15 PM ETCompany ParticipantsStephen Cootey - Executive ...

Fourth quarter 2024Net sales in the quarter amounted to SEK 577.5 m (494.2), which corresponds to net sales growth of 17% (9%). The growth was primarily driven by ...